Anxiety and depression in chronic obstructive pulmonary disease: a systematic review and meta-analysis
Anxiety and depression in chronic obstructive pulmonary disease: a systematic review and meta-analysis
Background: Growing evidence from research indicates that Chronic Obstructive Pulmonary Disease(COPD) can increase the likelihood of patients suffering from anxiety and depression. However, there is little consensus about the prevalence and associated risk factors. The primary aim of this study was to systematically review the prevalence of anxiety and depression in patients with COPD. The secondary aim was to identify risk factors contributing to the comorbidity.
Methods: The study was conducted following PRISMA guidelines and was registered on PROSPERO. MEDLINE, Embase, PsychInfo and Web of Science were used to select relevant studies before 1st January 2023. A total of 4,420 studies were gathered after the initial search. 39 papers were included after meeting inclusion and exclusion criteria. Quality assessment was conducted using Hawker’s tool. The pooled prevalence was calculated using the random effects model via Comprehensive Meta-Analysis.
Results: The total sample size was 84,411 including 17,489 for anxiety and 66,922 for depression. The pooled prevalence for anxiety and depression were 29.8%(95% CI: 24.7%-35.5%) and 28.5%(95% CI: 21.3%-36.9%), respectively. Reported risk factors included gender, BMI, smoking, and severity of COPD. I2 test results derived from meta-analyses revealed substantial heterogeneity across studies due to the variability in study design.
Conclusions: This is the first meta-analysis that provides precise comorbidity and risk estimates of anxiety and depression in COPD. The study indicates higher prevalence of anxiety and depression in COPD suggesting the need for early assessment. The study also highlights females, higher BMI, smoking, and COPD with more exacerbation are contributing risk factors. Further research is warranted to examine underlying inflammatory mechanisms and identify modifiable risk factors which may offer new intervention approaches to benefit COPD patients with anxiety and depression.
Miah, Alina
c0fb1ece-5ed1-4079-ae65-f69f49b09059
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376
13 September 2023
Miah, Alina
c0fb1ece-5ed1-4079-ae65-f69f49b09059
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376
Miah, Alina and Hou, Ruihua
(2023)
Anxiety and depression in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
ERS International Congress 2023 -European Respiratory Society (ERS), , Milan, Italy.
09 - 13 Sep 2023.
1 pp
.
Record type:
Conference or Workshop Item
(Poster)
Abstract
Background: Growing evidence from research indicates that Chronic Obstructive Pulmonary Disease(COPD) can increase the likelihood of patients suffering from anxiety and depression. However, there is little consensus about the prevalence and associated risk factors. The primary aim of this study was to systematically review the prevalence of anxiety and depression in patients with COPD. The secondary aim was to identify risk factors contributing to the comorbidity.
Methods: The study was conducted following PRISMA guidelines and was registered on PROSPERO. MEDLINE, Embase, PsychInfo and Web of Science were used to select relevant studies before 1st January 2023. A total of 4,420 studies were gathered after the initial search. 39 papers were included after meeting inclusion and exclusion criteria. Quality assessment was conducted using Hawker’s tool. The pooled prevalence was calculated using the random effects model via Comprehensive Meta-Analysis.
Results: The total sample size was 84,411 including 17,489 for anxiety and 66,922 for depression. The pooled prevalence for anxiety and depression were 29.8%(95% CI: 24.7%-35.5%) and 28.5%(95% CI: 21.3%-36.9%), respectively. Reported risk factors included gender, BMI, smoking, and severity of COPD. I2 test results derived from meta-analyses revealed substantial heterogeneity across studies due to the variability in study design.
Conclusions: This is the first meta-analysis that provides precise comorbidity and risk estimates of anxiety and depression in COPD. The study indicates higher prevalence of anxiety and depression in COPD suggesting the need for early assessment. The study also highlights females, higher BMI, smoking, and COPD with more exacerbation are contributing risk factors. Further research is warranted to examine underlying inflammatory mechanisms and identify modifiable risk factors which may offer new intervention approaches to benefit COPD patients with anxiety and depression.
Text
ANXIETY AND DEPRESSION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE A SYSTEMATIC REVIEW AND META-ANALYSIS
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Published date: 13 September 2023
Venue - Dates:
ERS International Congress 2023 -European Respiratory Society (ERS), , Milan, Italy, 2023-09-09 - 2023-09-13
Identifiers
Local EPrints ID: 506818
URI: http://eprints.soton.ac.uk/id/eprint/506818
PURE UUID: ff2f242a-ca61-49ef-914c-2fc57a4ea9fc
Catalogue record
Date deposited: 18 Nov 2025 18:10
Last modified: 19 Nov 2025 02:41
Export record
Contributors
Author:
Alina Miah
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics